Specifically I think the risk profile these companies have decided to take on is such that the government is basically investing to mitigate bad decision making. These are basically most of the biggest companies in the US right now. Also, I think Trump has shown that the primary criteria for this is not merit but graft.

If these companies were in an earlier more precarious part of their research cycle, and if like multiple of his advisors and his VP weren’t industry insiders or paid by such I might be more in favor. But this is basically regulatory capture in steroids.

The economy is centralized in the magnificent ten enough.